In the last trading session, 3.74 million shares of the Petros Pharmaceuticals Inc (NASDAQ:PTPI) were traded, and its beta was 2.16. Most recently the company’s share price was $0.05, and it changed around $0.0 or 0.00% from the last close, which brings the market valuation of the company to $2.55M. PTPI currently trades at a discount to its 52-week high of $0.94, offering almost -1780.0% off that amount. We note from Petros Pharmaceuticals Inc’s average daily trading volume that its 10-day average is 12.04 million shares, with the 3-month average coming to 35.68 million.
Petros Pharmaceuticals Inc stock received a consensus recommendation rating of Overweight, based on a mean score of 1.00. If we narrow it down even further, the data shows that 0 out of 1 analysts rate the stock as a Sell; another 1 rate it as Overweight. Among the rest, 0 recommended PTPI as a Hold, whereas 0 deemed it a Buy, and 0 rated it as Underweight. Petros Pharmaceuticals Inc is expected to report earnings per share of 0 for the current quarter.
Petros Pharmaceuticals Inc (NASDAQ:PTPI) trade information
The performance over the last five days has remained in the red territory. The rise to weekly highs of 0.0660 on recent trading dayincreased the stock’s daily price by 24.24%. The company’s shares are currently down -87.92% year-to-date, but still down -28.96% over the last five days. On the other hand, Petros Pharmaceuticals Inc (NASDAQ:PTPI) is -43.93% down in the 30-day period. We can see from the shorts that 1.48 million shares have been sold at a short interest cover period of 0.04 day(s).
Looking at the company’s year-over-year earnings, the past five years showed a positive earnings growth rate of 55.46%.
PTPI Dividends
Petros Pharmaceuticals Inc’s next quarterly earnings report is expected to be released on 2024-Nov-12.
Petros Pharmaceuticals Inc (NASDAQ:PTPI)’s Major holders
Upon looking at major shareholders, it appears that insiders hold 6.01% of Petros Pharmaceuticals Inc shares, and 4.86% of them are in the hands of institutional investors. The stock currently has a share float of 5.17%.
VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund and Fidelity Concord Street Trust-Fidelity Extended Market Index Fund were the top two Mutual Funds as of Dec 31, 2024 . The former held 31.81 shares worth $1514.0, making up 0.06% of all outstanding shares. On the other hand, Fidelity Concord Street Trust-Fidelity Extended Market Index Fund held roughly 34.65 shares worth around $1649.0, which represents about 0.06% of the total shares outstanding.
